118 related articles for article (PubMed ID: 26439843)
1. Construction of recombinant adenovirus containing picorna-viral 2A-peptide sequence for the co-expression of neuro-protective growth factors in human umbilical cord blood cells.
Garanina EE; Mukhamedshina YO; Salafutdinov II; Kiyasov AP; Lima LM; Reis HJ; Palotás A; Islamov RR; Rizvanov AA
Spinal Cord; 2016 Jun; 54(6):423-30. PubMed ID: 26439843
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule.
Islamov RR; Rizvanov AA; Mukhamedyarov MA; Salafutdinov II; Garanina EE; Fedotova VY; Solovyeva VV; Mukhamedshina YO; Safiullov ZZ; Izmailov AA; Guseva DS; Zefirov AL; Kiyasov AP; Palotas A
Curr Gene Ther; 2015; 15(3):266-76. PubMed ID: 25619885
[TBL] [Abstract][Full Text] [Related]
3. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
Rizvanov AA; Guseva DS; Salafutdinov II; Kudryashova NV; Bashirov FV; Kiyasov AP; Yalvaç ME; Gazizov IM; Kaligin MS; Sahin F; Mukhamedyarov MA; Palotás A; Islamov RR
Exp Biol Med (Maywood); 2011 Jan; 236(1):91-8. PubMed ID: 21163822
[TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy.
Rizvanov AA; Kiyasov AP; Gaziziov IM; Yilmaz TS; Kaligin MS; Andreeva DI; Shafigullina AK; Guseva DS; Kiselev SL; Matin K; Palotás A; Islamov RR
Neurochem Int; 2008 Dec; 53(6-8):389-94. PubMed ID: 18948156
[TBL] [Abstract][Full Text] [Related]
5. Tandem Delivery of Multiple Therapeutic Genes Using Umbilical Cord Blood Cells Improves Symptomatic Outcomes in ALS.
Islamov RR; Rizvanov AA; Fedotova VY; Izmailov AA; Safiullov ZZ; Garanina EE; Salafutdinov II; Sokolov ME; Mukhamedyarov MA; Palotás A
Mol Neurobiol; 2017 Aug; 54(6):4756-4763. PubMed ID: 27495938
[TBL] [Abstract][Full Text] [Related]
6. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
[TBL] [Abstract][Full Text] [Related]
7. Proangiogenic Effect of 2A-Peptide Based Multicistronic Recombinant Constructs Encoding VEGF and FGF2 Growth Factors.
Gatina DZ; Garanina EE; Zhuravleva MN; Synbulatova GE; Mullakhmetova AF; Solovyeva VV; Kiyasov AP; Rutland CS; Rizvanov AA; Salafutdinov II
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072943
[TBL] [Abstract][Full Text] [Related]
8. Cord blood as a potential therapeutic for amyotrophic lateral sclerosis.
Garbuzova-Davis S; Ehrhart J; Sanberg PR
Expert Opin Biol Ther; 2017 Jul; 17(7):837-851. PubMed ID: 28443372
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of Oct4 and Sox2 transcription factors enhances differentiation of human umbilical cord blood cells in vivo.
Guseva D; Rizvanov AA; Salafutdinov II; Kudryashova NV; Palotás A; Islamov RR
Biochem Biophys Res Commun; 2014 Sep; 451(4):503-9. PubMed ID: 25124662
[TBL] [Abstract][Full Text] [Related]
10. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
Knippenberg S; Thau N; Schwabe K; Dengler R; Schambach A; Hass R; Petri S
Neurodegener Dis; 2012; 9(3):107-20. PubMed ID: 22122965
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the efficiency of gene-cell therapy in transgenic mice with amyotrophic lateral sclerosis phenotype.
Mukhamedyarov MA; Rizvanov AA; Safiullov ZZ; Izmailov AA; Sharifullina GA; Solovieva VV; Fedotova VY; Salafutdinov II; Cherenkova EE; Bashirov FV; Kaligin MS; Abdulkhakov SR; Shmarov MM; Logunov DY; Naroditsky BS; Kiyasov AP; Zefirov AL; Islamov RR
Bull Exp Biol Med; 2013 Feb; 154(4):558-61. PubMed ID: 23486603
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS.
Zheng C; Nennesmo I; Fadeel B; Henter JI
Ann Neurol; 2004 Oct; 56(4):564-7. PubMed ID: 15389897
[TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration.
Bigini P; Veglianese P; Andriolo G; Cova L; Grignaschi G; Caron I; Daleno C; Barbera S; Ottolina A; Calzarossa C; Lazzari L; Mennini T; Bendotti C; Silani V
Rejuvenation Res; 2011 Dec; 14(6):623-39. PubMed ID: 21978082
[TBL] [Abstract][Full Text] [Related]
14. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
Acsadi G; Anguelov RA; Yang H; Toth G; Thomas R; Jani A; Wang Y; Ianakova E; Mohammad S; Lewis RA; Shy ME
Hum Gene Ther; 2002 Jun; 13(9):1047-59. PubMed ID: 12067438
[TBL] [Abstract][Full Text] [Related]
15. [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].
Ismailov ShM; Barykova IuA; Shmarov MM; Tarantul VZ; Barskov IV; Kucherianu VG; Brylev LV; Logunov DIu; Tutykhina IL; Bocharov EV; Zakharova MN; Naroditskiĭ BS; Illarioshkin SN
Genetika; 2014 May; 50(5):591-601. PubMed ID: 25715475
[TBL] [Abstract][Full Text] [Related]
16. [Effects of transplantation of human umbilical cord blood mononuclear cells, expressing VEGF and FGF2 genes, into the area of spinal cord traumatic lesion].
Shaĭmardanova GF; Mukhamedshina IaO; rizvanov AA; Salafutdinov II; Chelyshev IuA
Morfologiia; 2012; 142(4):31-6. PubMed ID: 23236888
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1.
Fukada Y; Yasui K; Kitayama M; Doi K; Nakano T; Watanabe Y; Nakashima K
Brain Res; 2007 Jul; 1160():1-10. PubMed ID: 17583678
[TBL] [Abstract][Full Text] [Related]
18. Usage of plasmid vector carrying vegf and fgf2 genes after spinal cord injury in rats.
Shaymardanova GF; Mukhamedshina YO; Salafutdinov II; Rizvanov AA; Chelyshev YA
Bull Exp Biol Med; 2013 Feb; 154(4):544-7. PubMed ID: 23486600
[TBL] [Abstract][Full Text] [Related]
19. Influence of Recombinant Codon-Optimized Plasmid DNA Encoding VEGF and FGF2 on Co-Induction of Angiogenesis.
Salafutdinov II; Gazizov IM; Gatina DK; Mullin RI; Bogov AA; Islamov RR; Kiassov AP; Masgutov RF; Rizvanov AA
Cells; 2021 Feb; 10(2):. PubMed ID: 33670607
[TBL] [Abstract][Full Text] [Related]
20. Gene and protein therapies utilizing VEGF for ALS.
Keifer OP; O'Connor DM; Boulis NM
Pharmacol Ther; 2014 Mar; 141(3):261-71. PubMed ID: 24177067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
